Oxygen-dependent PAF receptor binding and intracellular signaling in ovine fetal pulmonary vascular smooth muscle

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 288, Issue 5 32-5, 2005, Pages

  Ibe, Basil O ^a   Portugal, Ada M ^a   Chaturvedi, Shiva ^a   Raj, J Usha ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Calcium; Hypoxia; Inositol phosphates; Platelet activating factor; Receptor phosphorylation; Vasomotor tone

Indexed keywords

CALCIUM; CYCLOHEXIMIDE; INOSITOL TRISPHOSPHATE; OXYGEN; PROTEIN SYNTHESIS INHIBITOR; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; COW; FETUS; FETUS HYPOXIA; FETUS LUNG; LUNG BLOOD VESSEL; LUNG VASOCONSTRICTION; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; RECEPTOR DENSITY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSLATION REGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANOXIA; CALCIUM; FEMALE; FETAL HYPOXIA; INOSITOL PHOSPHATES; LUNG; MUSCLE, SMOOTH, VASCULAR; OXYGEN; PHOSPHORYLATION; PLATELET MEMBRANE GLYCOPROTEINS; PREGNANCY; RECEPTORS, G-PROTEIN-COUPLED; SHEEP; SIGNAL TRANSDUCTION;

EID: 17444418986     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00341.2004     Document Type: Article

References (58)

1. 4 generation and chemokine production. J Biol Chem 277: 22685-22691, 2002.
2. Ali H, Fisher I, Haribabu B, Richardson RM, and Snyderman. Role of phospholipase Cβ3 phosphorylation in the desensitization of cellular response to platelet-activating factor. J Biol Chem 272: 11706-11709, 1997.
3. Ali H, Richardson RM, Tomhave ED, Dubose RA, Haribabu B, and Snyderman R. Regulation of stably transfected platelet activating factor receptor in RBL-2H3 cells. J Biol Chem 269: 24557-24563, 1994.
4. Argiolas L, Fabi F, and del Basso P. Mechanisms of pulmonary vasoconstriction and bronchoconstriction produced by PAF in guinea-pig: role of platelets and cyclo-oxygenase metabolites. Br J Pharmacol 114: 203-209, 1995.
5. Belouchi NE, Roux E, Savineau JP, and Marthan R. Effect of chronic hypoxia on calcium signaling in airway smooth muscle cells. Eur Respir J 14: 74-79, 1999.
6. Bhaikly G, Pothier P, D'Orleans-Juste P, Simaan M, Jacques D, Jaalouk D, Belzile F, Hassa G, Boutin C, Haddad G, and Neugebauer W. The use of confocal microscopy in the investigation of cell structure and function in the heart, vascular endothelium and smooth muscle cells. Mol Cell Biochem 172: 171-194, 1997.
7. 2+ channel in human and canine aortic endothelial cells. Br J Pharmacol 110: 519-520, 1993.
8. Caplan MS, Hsueh W, Sun XM, Gidding SS, and Hageman JR. Circulating plasma platelet activating factor in persistent pulmonary hypertension of the newborn (PPHN). Am Rev Respir Dis 142: 1258-1262, 1990.
9. Carlson SA, Chatterjee TK, and Fisher RA. The third intracellular domain of the platelet-activating factor receptor is a critical determinant in the receptor coupling to phosphoinositide phospholipase C activating G proteins. J Biol Chem 272: 23146-23153, 1996.
10. Chatterjee TK, Eapen AK, and Fisher RA. A truncated form of RGS3 negatively regulates G-protein-coupled receptor stimulation of adenyl cyclase and phosphoinositide phospholipase C. J Biol Chem 272: 15481-15487, 1997.
11. Centemeri C, Colli S, Tosarello D, Ciceri P, and Nicosia S. Heterogenous platelet-activating factor (PAF) receptors and calcium increase in platelets and macrophages. Biochem Pharmacol 57: 263-271, 1999.
12. Chen D and Chen W. Changes in distribution of platelet activating factor in lung of rats with hypoxic pulmonary hypertension. Chin Med J (Engl) 109: 776-779, 1996.
13. Cliang A, Shbaklo H, Plante M, Bhaikly G, and D'Orleans-Juste P. Comparison of the contractile and calcium-increasing properties of platelet-activating factor and endothelin-1 in the rat mesenteric artery and vein. Br J Pharmacol 135: 433-443, 2002.
14. Dearn S, Rahman M, Lewis A, Ahmed Z, Eggo MC, and Ahmed A. Activation of platelet-activation factor (PAF) receptor stimulates nitric oxide (NO) release via protein kinase C-α in HEC-1b human endometrial epithelial cell line. Mol Med 6: 37-49, 2000.
15. Denizot Y, Dupuis F, Trimoreau F, Verger C, Allegraud A, and Praloran V. PAF and hematopoiesis: IX. Platelet-activating factor increases DNA synthesis in human bone marrow cells. J Lipid Mediat Cell Signal 15: 1-4, 1996.
16. Fukunaga K, Ishii S, Asano K, Yokomizo T, Shiomi T, Shimizu T, and Yamaguchi K. Single nucleotide polymorphism of human platelet-activating factor receptor impairs G-protein activation. J Biol Chem 276: 43025-43030, 2001.
17. Gao Y, Zhou H, and Raj JU. PAF induces relaxation of pulmonary arteries but contraction of pulmonary veins in the ferret. Am J Physiol Heart Circ Physiol 269: H704-H709, 1995.
18. 4 receptor (BLT1) is crucial for ligand-induced, G-protein-coupled receptor-specific kinase 6-mediated desensitization. J Biol Chem 277: 31567-31576, 2002.
19. - currents in rabbit arterial and portal vein smooth muscle cells. J Physiol 534: 395-408, 2001.
20. 2+. I. response by SERCA inhibitors in cerebral arterioles. Br J Pharmacol 135: 927-934, 2002.
21. Hall SM and Haworth SG. Onset and evolution of pulmonary vascular disease in young children: abnormal postnatal remodeling studied in lung biopsies. J Pathol 166: 183-193, 1992.
22. Han JM, Kim JH, Lee BD, Lee SD, Kim Y, Jung YW, Lee S, Cho W, Ohba M, Kuroki T, Suh PG, and Ryu SH. Phosphorylation-dependent regulation of phospholipase D2 by protein kinase Cδ in rat pheochromocytoma PC12 cells. J Biol Chem 277: 8290-8297, 2002.
23. Hepler JR and Gilman AG. G proteins. Trends Biochem Sci 17: 383-387, 1992.
24. Heyman MA, Creasy RK, and Rudolph AM. Quantitation of blood flow patterns in fetal lamb in utero. In: Proceedings of the Sir Bancroft Symposium: Foetal and Neonatal Physiology. Cambridge, UK: Cambridge University Press, 1990, p. 129.
25. Ibe BO, Hibler S, and Raj JU. Platelet-activating factor modulates pulmonary vasomotor tone in the perinatal period. J Appl Physiol 85: 1079-1085, 1998.
26. Ibe BO, Pham HH, Kääpä P, and Raj JU. Maturational changes in ovine pulmonary metabolism of platelet-activating factor: Implications for postnatal adaptation. Mol Genet Metab 74: 385-395, 2001.
27. 2 protein expression and activities of acetyl-CoA acetyltransferase and cholinephosphotransferase. Mol Genet Metab 77: 237-248, 2002.
28. Ibe BO, Sander FC, and Raj JU. Platelet-activating factor receptors in lamb lungs are downregulated immediately after birth. Am J Physiol Heart Circ Physiol 278: H1168-H1176, 2000.
29. Ibe BO and Raj JU. Leukotriene metabolism by intrapulmonary vessels of newborn lambs. Effect of platelet activating factor. Exp Lung Res 27: 331-348, 2001.
30. Ishii I, Saito E, Izumi T, Ui M, and Shimizu T. Agonist-induced sequestration, recycling, and resensitization of platelet-activating factor receptor. J Biol Chem 273: 9878-9885, 1998.
31. Ishii S and Shimizu T. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog Lipid Res 39: 41-82, 2001.
32. Jeanneton O, Delvaux M, Botella A, Frexinos J, and Bueno L. Platelet-activating factor (PAF) induces a contraction of smooth muscle cell from guinea pig ileum: intracellular pathway involved. J Pharmacol Exp Ther 267: 31-37, 1993.
33. Kääpä P, Raj JU, Ibe BO, and Anderson J. Effect of pentoxyfylline in rabbit pulmonary circulation: influence of age and vasomotor tone. Am J Physiol Heart Circ Physiol 261: H975-H981, 1991.
34. i rise in rabbit pulmonary arterial smooth muscle cells. Life Sci 29: 2321-2333, 2002.
35. Korth RM. Specific high affinity binding of platelet activating factor to intact human blood neutrophils and eosinophils. Int Arch Allergy Immunol 110: 124-131, 1996.
36. Korth RM, Hirafuji M, Benveniste J, and Russo-Marie F. Human umbilical vein endothelial cells: specific binding of platelet-activating factor and cytosolic calcium flux. Biochem Pharmacol 49: 1793-1799, 1995.
37. Lin AY and Rui YC. Platelet-activating factor induced calcium mobilization and phosphoinositide metabolism in cultured bovine cerebral microvascular endothelial cells. Biochim Biophys Acta 1224: 323-328, 1994.
38. Lou YP, Takeyama K, Grattan KM, Lausier JA, Ueki IF, Agusti C, and Nadel JA. Platelet-activating factor induces goblet cell hyperplasia and mucin gene expression in airways. Am J Respir Crit Care Med 157: 1927-1934, 1998.
39. Martin C, Goggle R, Ressmeyer AR, and Uhlig S. Pressor responses to platelet-activating factor and thromboxane are mediated by Rho-kinase. Am J Physiol Lung Cell Mol Physiol 287: L250-L257, 2004.
40. McDonald PH and Lefkowitz RJ. New roles in regulating heptahelical receptors' functions. Cell Signal 13: 683-689, 2001.
41. Minamino T, Mitsailis SA, and Kourembanas S. Hypoxia extends the life span of vascular smooth muscle cells through telomerase activation. Mol Cell Biol 21: 3336-3342, 2001.
42. 2+/calmodulin-dependent protein kinase II in vascular smooth muscle cells. Am J Pathol 161: 1893-1901, 2002.
43. 2+ release from ryanodine-sensitive store contributes to mechanism of hypoxic vasoconstriction in rat lung. J Appl Physiol 92: 527-534, 2002.
44. Nakamura M, Honda ZI, Izumi Takashi Sakanaka C, Mutoh H, Minami M, Bito H, Seyama Y, Matsumoto T, Noma M, and Shimizu T. Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J Biol Chem 266: 20400-20405, 1991.
45. Neer EJ. Heterotrimeric G proteins: organizers of transmembrane signals. Cell 80: 249-257, 1996.
46. Ono S, Westcott JY, and Voelkel NF. PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats. J Appl Physiol 73: 1084-1092, 1992.
47. Parent JL, Le Gouill C, Escher E, Rola-Pleszcynski M, and Stankova J. Identification of transmembrane domain residues determinant in the structure-function relationship of human platelet-activating factor receptor by site directed mutagenesis. J Biol Chem 271: 23298-23303, 1996.
48. Pauly RR, Bilato C, Cheng L, Monticone R, and Crow MT. Vascular smooth muscle cells cultures. Methods Cell Biol 52: 133-154, 1998.
49. 2 in ferret lungs. Respir Physiol 88: 129-140, 1992.
50. Roth M, Nauck M, Yousefi S, Tamm M, Blaser K, Perruchoud AP, and Simon UU. Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin-6 and interleukin-8 in human lung fibroblast via binding to its functional receptor. J Exp Med 184: 191-201, 1996.
51. Salva AML, Ibe BO, Cliborn E, Reyes G, and Raj JU. Hypoxia attenuates metabolism of platelet activating factor by fetal and newborn lamb lungs. J Lipid Res 37: 783-789, 1996.
52. Smith JB, Selak MA, Dangelmaier C, and Daniel JL. Cytosolic calcium as a second messenger for collagen-induced platelet responses. Biochem J 288: 925-929, 1992.
53. Thomas SR, Chen K, and Keaney JF Jr. Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway. J Biol Chem 277: 6017-6024, 2002.
54. Toga H, Ibe BO, and Raj JU. Vascular effects of platelet-activating factor in lambs: role of cyclo- and lipoxygenase. J Appl Physiol 73: 2559-2566, 1992.
55. Wang YX, Zheng YM, Abdullaev I, and Kotlikoff MI. Metabolic inhibition with cyanide induces calcium release in pulmonary artery myocytes and Xenopus oocytes. Am J Physiol Cell Physiol 284: C378-C388, 2003.
56. Wohrley JD, Frid MG, Moiseeva EP, Orton EC, Belknap JK, and Stenmark KR. Hypoxia selectively induces proliferation in a specific subpopulation of smooth muscle cells in the bovine neonatal pulmonary arterial media. J Clin Invest 96: 273-281, 1995.
57. Wu D, Jiang Katz A H, and Simon MI. Identification of critical regions on phospholipase C-beta 1 required for activation by G-proteins. J Biol Chem 268: 3704-3709, 1993.
58. Zhang J, Jin N, Liu Y, and Rhoades RA. Hydrogen peroxide stimulates extracellular signal-regulated protein kinases in pulmonary arterial smooth muscle cells. Am J Respir Cell Mol Biol 19: 324-332, 1998.